» Articles » PMID: 26597834

Breast MRI Background Parenchymal Enhancement (BPE) Correlates with the Risk of Breast Cancer

Overview
Publisher Elsevier
Specialty Radiology
Date 2015 Nov 25
PMID 26597834
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate whether background parenchymal enhancement (BPE) and breast cancer would correlate searching for any significant difference of BPE pattern distribution in case of benign or malignant lesions.

Methods: 386 patients, including 180 pre-menopausal (group 1) and 206 post-menopausal (group 2), underwent MR examination. Two radiologists evaluated MR images classifying normal BPE as minimal, mild, moderate or marked. The two groups of patients were subdivided into 3 categories based on MRI findings (negative, benign and malignant lesions). The distribution of BPE patterns within the two groups and within the three MR categories was calculated. The χ2 test was used to evaluate BPE type distribution in the three patient categories and any statistically significant correlation of BPE with lesion type was calculated. The Student t test was applied to search for any statistically significant difference between BPE type rates in group 1 and 2.

Results: The χ2 test demonstrated a statistically significant difference in the distribution of BPE types in negative patients and benign lesions as compared with malignant ones (p<0.05). A significantly higher prevalence of moderate and marked BPE was found among malignant lesions (group 1: 32% and 42%, respectively; group 2: 31% and 46%, respectively) while a predominance of minimal and mild BPE among negative patients (group 1: 60% and 36%, respectively; group 2: 68% and 32%, respectively) and benign lesions (group 1: 54% and 38%, respectively; group 2: 75% and 17%, respectively) was found. The Student t test did not show a statistically significant difference between BPE type rates in group 1 and 2 (p>0.05).

Conclusion: Normal BPE could correlate with the risk of breast cancer being such BPE patterns as moderate and marked associated with patients with malignant lesions in both pre and post-menopausal women.

Citing Articles

Influence of Breast Density and Menopausal Status on Background Parenchymal Enhancement in Contrast-Enhanced Mammography: Insights from a Retrospective Analysis.

Nicosia L, Mariano L, Mallardi C, Sorce A, Frassoni S, Bagnardi V Cancers (Basel). 2025; 17(1.

PMID: 39796642 PMC: 11718959. DOI: 10.3390/cancers17010011.


Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors: Evaluating Background Parenchymal Enhancement and Radiotherapy-Induced Toxicity.

Laddaga F, Telegrafo M, Garzillo C, Fiorentino A, Sardaro A, Martinotti S Cancers (Basel). 2024; 16(23).

PMID: 39682278 PMC: 11639875. DOI: 10.3390/cancers16234091.


MRI Evaluation of Mass-Like and None-Mass-Like-Proven Breast Cancer from Moderate-to-High Background Enhancement.

Farghadani M, Sanei P Adv Biomed Res. 2024; 13:36.

PMID: 39234434 PMC: 11373728. DOI: 10.4103/abr.abr_221_21.


Predicting pathological complete response to neoadjuvant chemotherapy in breast cancer patients: use of MRI radiomics data from three regions with multiple machine learning algorithms.

Zheng G, Peng J, Shu Z, Jin H, Han L, Yuan Z J Cancer Res Clin Oncol. 2024; 150(3):147.

PMID: 38512406 PMC: 10957588. DOI: 10.1007/s00432-024-05680-y.


Beyond Breast Density: Risk Measures for Breast Cancer in Multiple Imaging Modalities.

Acciavatti R, Lee S, Reig B, Moy L, Conant E, Kontos D Radiology. 2023; 306(3):e222575.

PMID: 36749212 PMC: 9968778. DOI: 10.1148/radiol.222575.